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Abstract 
In the present communication, we describe tandem combinations of Suzuki – condensation ring 
closure reactions to obtain a novel thieno[3′,2′:4,5]pyrido[2,3-d]pyridazine ring system. These 
compounds were studied by tandem mass spectrometry in detail and characteristic fragmentations 
were observed, which can be useful to confirm the presence of N-substituted pyridazine ring in 
synthesized compounds. 
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Introduction 
 
In our previous studies1-4 we reported the synthesis of fused nitrogen-containing ring systems, 
several tandem reactions included.5-7 In this paper the application of Suzuki – condensation ring 
closure tandem reaction is described for the synthesis of a novel thieno[3′,2′:4,5]pyrido[2,3-
d]pyridazine ring system. Among starting material of our previous works also 5-azido-4-
bromopyridazin-3(2H)-ones derivatives have been applied for synthesis route 
azide→iminophosphorane→Suzuki-aza-Wittig tandem reaction. The 4-halo-5-iminophosphoranes 
were prepared from the reaction of the related azides with triphenylphosphine and followed by the 
reaction with 2-formylarylboronic acid to obtain a tricyclic ring system. The 5-azido-4-halo 
precursors could be selectively obtained from dihalo compounds. On the contrary, the 4-azido-5-
bromopyridazin-3(2H)-ones regioisomers could not be prepared (under apolar conditions by sodium 
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azide, anhydrous toluene, 15-crown-5, heating) from the appropriate 4,5-dibromopyridazine 
derivatives, so the other regioisomer of this previously tricyclic system could not be obtained from 
haloazide precursor. That is why haloamines of pyridazinones were applied in our present work as 
starting materials, which could be synthesized from the appropriate dibromo-pyridazinones. After 
reaction with aqueous ammonia the regioisomer haloamines could be separated by recrystallization, 
respectively by flash chromatography purification of the mother liquor. From these two isolated 
isomers were carried out separately Suzuki-condensation tandem reactions for synthesis of two 
regioisomers of novel thieno[3′,2′:4,5]pyrido[2,3-d]pyridazine ring system. 
Moreover, MS investigations of the obtained target compounds were performed, similar to 
published MS study.8 Main aim of these examinations is the observation of the similarity and 
differences in LC-MS behaviour of these two tricyclic regioisomers. Following some relevant 
articles have been shown the different cleavages of pyridazine derivatives. The ring contraction 
reactions of pyridazines were supposed by density functional theory computations.9 Other papers 
are concerning on thermal cleavages and photolysis of pyridazines10 as well as mass spectrometric 
investigation of pyridazine derivatives, whereby fragments were identified, which have been 
produced by UV photons.11 
 
Results and Discussion 
 
(i) Synthesis of target compounds 
In this case haloamines 2 and 3 - obtained in first step from the N-benzyl-4,5-dibromopyridazinone 
1 through halogen displacements by ammonia - were transformed to thieno[3′,2′:4,5]pyrido[2,3-
d]pyridazines 4 and 5 via Suzuki – condensation tandem reaction using 2-formyl-3-thiophene-
boronic acid12 (Scheme 1). 
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Scheme 1. Halogen displacements on halopyridazinones by ammonia and subsequent Suzuki-
condensation tandem reactions of pyridazinones. 
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(ii) HPLC-MS and MS/MS analysis of the target compounds 
HPLC-MS analysis was performed to investigate the purity of compounds 4 and 5 (we found that 
the purity > 99%). Mass spectra of the two compounds were recorded with the aim of distinguishing 
the isomers from each other. On the chromatogram of isomer 4 the retention time of this compound 
is 8.07 min. On the mass spectrum m/z=294 belongs to this peak. 
On the chromatogram of compound 5, the retention time of this compound is 6.33 min, 
m/z=294, m/z=316, m/z=587 and m/z=609 belong to this peak. The main difference between the 
mass spectra of the two isomers is the presence of some special ions in the spectrum of 5 besides the 
main signal. The main components are the sodium adduct of 5 (m/z=316), the protonated dimer of 5 
(m/z=587), and the sodium adduct of this dimer (m/z=609). These adducts have significant signals 
besides the signal of compound 5 and they can be found only as minor components in the spectrum 
of the other isomer (4). 
HPLC-MS/MS spectrum of compound 4 displays m/z=189 as a main fragment and some minor 
fragments e.g. m/z=106, m/z=135, m/z=147, m/z=175, which are not observed in the spectrum of 
compound 5. The structure of this fragment and its exact mass are shown in Scheme 2. 
The components have been identified with 3 ppm mass accuracy.  
 
  
 
Scheme 2. The mass spectrometric fragmentation process of isomer (4). 
 
These MS data are according with the results of NMR structure determination. The signal 
assignment was based on 1H, 13C, HSQC and HMBC NMR experiments. The differentiation of the 
two regioisomers was based on NOE difference experiment. In case of compound 5, H-1 was 
irradiated. In the difference spectrum NOE intensity increasement was observed on H-9. (Figure 1.) 
An additional proof is the chemical shift difference of H-9s in the two regioisomers. In case of 
compound 4, where H-9 is in the vicinity of the carbonyl group a huge downfield chemical shift 
(0.92 ppm) can be observed. (Figure 2.) 
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Figure 1. NOE difference spectrum of compound 5 (H-1 was irradiated). 
 
 
 
 
Figure 2. 1H NMR spectra of compound 4 and 5 (aromatic section). 
 
(iii) Tandem mass spectrometric study of compounds 4, 5 and of further isomers 
The fragmentation behaviour of the isomers (compounds 4 and 5) have been studied by tandem 
mass spectrometry (Figure 3.). For both isomers poor fragmentation was observed, the benzyl 
cation formation (m/z=91) is the largest peak in the tandem mass spectra. There are, however, 
significant difference in the fragmentation pattern of the isomers close to the N-2 atoms. Schematic 
diagram of the tandem mass spectrometric fragmentation of isomers is shown on Figure 4. 
Compound 4 relatively easily forms cross ring fragments (m/z=189, m/z=147), which cannot be 
observed in the case of compound 5. On the other hand, fragment m/z=216 can only be noticed in 
the case of compound 5, which is probably produced by cleavage of the aromatic ring. These 
fragments make it possible to discriminate the 2 isomers on the basis of their tandem mass 
spectrometric behaviour.  
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LC-MS study of compounds 4 and 5 shows, that the isomers can be discriminated by their 
retention time on reversed phase HPLC and these results confirms that by tandem mass 
spectrometry as well.  
 
3a 
 
 
 
3b 
 
 
Figure 3. Tandem mass spectra of isomers (Figure 3a: compound 4, Figure 3b: compound 5). 
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Figure 4. Fragmentation schemes of isomers (Figure 4a: compound 4, Figure 4b: compound 5). 
 
It is instructive to compare the fragmentation behaviour of compound 4 and 5 to other similar 
compounds (Figure 5.). The benzyl group containing compounds (compound 61,5 and 71,5) show 
similar fragmentation. The formation of benzyl cation (m/z=91) is the highest peak in the tandem 
mass spectra and its counter ion can also be observed in the case of compound 6 (m/z=198).  
The location of the CO group significantly determines the fragmentation behaviour of the 
compounds. If the O is connected to the position 1 (eg. compound 6 and 4) intensive cross ring 
fragments are formed. If the O is at the position 4 (eg. compound 7 and 5) no cross ring fragments 
can be observed.  
On the other hand if the benzyl group is missing (compounds 81,5 and 91,5) the fragmentation 
pattern of the 2 molecules are similar (m/z=155, m/z=153, m/z=141, m/z=128), but the intensities of 
fragment ions are completely different and the two isomers can also be distinguished. The peak at 
m/z=128 is the most intense peak in the case of compound 8, while m/z=153 is the base peak in the 
tandem mass spectrum in the case of compound 9. 
These special characteristics of the tandem mass spectra can be utilized for the distinction of 
various regioisomers. 
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5a. 2-Benzylpyridazino[4,5-c]isoquinolin-1(2H)-one. 
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5b. 3-Benzylpyridazino[4,5-c]isoquinolin-4(3H)-one. 
 
 
 
5c. 2-Methylpyridazino[4,5-c]isoquinolin-1(2H)-one. 
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5d. 3-Methylpiridazino[4,5-c]isoquinolin-4(3H)-one. 
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Figure 5. Fragmentation schemes of isomers (Figure 5a: compound 6, Figure 5b: compound 7, 
Figure 5c: compound 8, Figure 5d: compound 9). 
 
 
Conclusions 
 
We applied Suzuki cross-coupling methodology for the facile synthesis of a novel 
thieno[3′,2′:4,5]pyrido[2,3-d]pyridazine ring system, and elaborated an LC-MS investigation 
procedure for the regioisomer compounds. The main aim of the present manuscript was to 
investigate the fragmentation behaviour of fused pyridazine type compounds. Major fragment of 
isomer 4 (m/z=189), which characterizes the fragmentation of pyridazine part, was not observed in 
the case of isomer 5. The number of fragments and mass of pyridazine ring fragments largely 
depend on the attachment of thienopyridine moiety. The isomer 4 showed a high degree of 
fragmentation as compared to the isomer 5. In the case of the other isomer pair (compounds 8, 9) 
similar fragmentation could be observed during the cleavage of pyridazin part (m/z=155, m/z=141, 
m/z=128), which represents methyl substituent containing pyridazine ring. In contrast, benzyl 
substituent containing isomers (compounds 6 and 7) showed far less fragmentation compared to the 
N-methyl substituted analogue compounds. This method can be used for study of substituent-
dependent, N-substituted pyridazine rings and for confirmation of the presence of pyridazine ring in 
synthesized compounds.  
 
 
Experimental Section 
 
General. 1H and 13C-NMR spectra were recorded on a Varian MERCURY plus (1H NMR 400 
MHz; 13C NMR 100 MHz) spectrometer in the solvent indicated at room temperature, using the 2H 
signal of the solvent as the lock. The 1H and 13C chemical shifts were referred to TMS (δTMS=0 
ppm). Chemical shifts (δ) are given in ppm and coupling constant (J) values in Hz. The structures of 
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compounds were elucidated using COSY, HSQC, HMBC (NMR) methods. Melting points were 
determined in a Büchi B-540 Melting Point apparatus and the values are uncorrected. IR spectra 
were recorded in potassium bromide pellets with a Perkin-Elmer 1600 FT-IR spectrophotometer. 
Solvent mixtures used for chromatography are always given in a vol/vol ratio. HPLC purity 
measurements were run on a JASCO LC-Net II/ADC system with a JASCO MD-2010 Plus diode 
array detector, on a Gemini NX C18 RP 25 cm × 4.6 mm 5 µm column, if not indicated otherwise, 
with the conditions given below (flow rate: 0.5 mL/min). Commercially available solvents were 
purified by standard procedures prior to use, whereas reagents (Reanal, Budapest or Sigma-Aldrich 
Kft., Budapest) were used as received. Standard flash chromatography on silica (Kieselgel 60, 
Aldrich, 0.040-0.063 mm) and/or recrystallization as indicated, was applied for purification of crude 
products. Thin layer chromatography was done on commercially available silica plates (Silica gel 
60 F254, Merck). 
Compounds 1,13 2,14 and 35 were synthesized according to the literature. 
 
General procedure for the synthesis of 4, 5 via Suzuki-reaction from the appropriate 
haloamines. A round-bottom flask was purged with argon and charged with the amino derivative 2 
or 3 (1.05 g, 3.70 mmol), tetrakis(triphenylphosphine)-palladium(0) (0.27 g, 0.23 mmol), and dry 
1,2-dimethoxyethane (40 mL). While stirring, the mixture was flushed with argon for approximately 
20 min. Subsequently 2-formyl-3-thiophene-boronic acid (0.88 g, 5.64 mmol) and sodium carbonate 
solution (2 M, 3.5 mL) were added, and the reaction mixture was heated at 110 °C for 12 hours. The 
reaction mixture was poured onto ice-water (25 mL), was extracted with dichloromethane (3x25 
mL) and the combined organic layers were dried over anhydrous sodium sulphate. The solvent was 
evaporated in vacuum and the residue after grinding by diethyl-ether was purified by flash column 
chromatography and crude solid product was recrystallized from dry ethanol. 
2-Benzylthieno[3′,2′:4,5]pyrido[2,3-d]pyridazin-1(2H)-one (4). Starting from 5-amino-2-benzyl-
4-bromopyridazin-3(2H)-one (2)14, eluent used for flash column chromatography: chloroform. Pale 
brown crystals, yield 40%, 0.434 g, mp 142.2-142.8°C; Rf (chloroform): 0.22. IR (νmax, cm-1): 3426, 
3114, 3062, 2924, 2856, 1646, 1488, 1452, 1314, 1264, 1216, 750, 696. δH (CDCl3 400 MHz): 9.47 
(s, 1H, H-6), 8.80 (d, J8,9 6 Hz, 1H, H-9), 8.57 (s, 1H, H-4), 8.05 (d, 1H, H-8), 7.50 (d, J2′,3′ 12 Hz, 
2H, H-2′,6′), 7.34 (m, 2H, H-3′,5′), 7.28 (m, 1H, H-4′), 5.51 (s, 2H, CH2); δC (CDCl3 100 MHz): 
159.9 (C-1), 150.7 (C-6), 143.4 (C-4a), 142.3 (C-9a)*, 140.2 (C-4), 139.4 (C-6a)*, 137.3 (C-1′), 
136.0 (C-8), 129.3 (C-3′,5′), 129.2 (C-2′,6′), 128.5 (C-4′), 126.3 (C-9), 119.8 (C-9b), 55.7 (CH2). H′, 
C′ are phenyl protons and carbons. MS: 189, 294. HRMS (ESI): C16H11N3OS [M+H]+: calculated 
294.0701; measured 294.0702. 
*signals are interchangeable 
3-Benzylthieno[3′,2′:4,5]pyrido[2,3-d]pyridazin-4(3H)-one (5). Starting from 4-amino-2-benzyl-
5-bromopyridazin-3(2H)-one (3)5, eluent used for flash column chromatography: chloroform:ethyl 
acetate=4:1. Pale gray crystals, yield 30%, 0.326 g, mp 258-258.5°C; Rf (chloroform:ethyl 
acetate=4:1): 0.22. IR (νmax, cm-1): 3074, 3034, 2950, 1654, 1584, 1546, 1492, 1458, 1430, 1356, 
1196, 760, 694. δH (CDCl3 400 MHz): 9.50 (s, 1H, H-6), 7.86 (d, J8,9 6 Hz, 1H, H-9), 8.60 (s, 1H, 
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H-1), 8.03 (d, 1H, H-8), 7.52 (d, J2′,3′ 12 Hz, 2H, H-2′,6′), 7.32 (m, 2H, H-3′,5′), 7.27 (m, 1H, H-4′), 
5.54 (s, 2H, CH2); δC (CDCl3 100 MHz): 159.8 (C-4), 149.1 (C-6), 140.4 (C-9a)*, 140.2 (C-6a)*, 
139.8 (C-4a), 137.3 (C-1′), 136.0 (C-8), 134.2 (C-1), 129.5 (C-2′,6′), 129.2 (C-3′,5′), 128.5 (C-4′), 
121.8 (C-9b), 121.4 (C-9), 55.6 (CH2). H′, C′ are phenyl protons and carbons. MS: 189, 294, 316, 
587, 609. HRMS (ESI): C16H11N3OS [M+H]+: calculated 294.0701; measured 294.0703. 
*signals are interchangeable 
 
HPLC-MS measurement 
The two isomers were separated before the MS measurement by AcquityTM UPLC System (Waters, 
Milford, MA, USA), which consisted of a column manager [column: Acquity BEH 1.7 µm, C18 1.0 
x 150 mm (Waters, Milford, MA, USA)], sample manager, binary solvent manager, photodiode 
array detector (wavelength here: 210–450 nm DAD) and MassLynx Software 4.1. The 
concentration of the sample was ~ 0.2 mg/mL, the solvent was in both cases acetonitrile:water = 
50:50. Sample injection volume was 5 µL, the flow rate was 0.10 mL/min and the run time was 15 
min. Gradient elution was applied, eluent A contained 85% water, 5% acetonitrile and 10% 0.1 M 
ammonium acetate solution, eluent B contained 90% acetonitrile and 10% 0.1 M ammonium acetate 
solution. The gradient table can be seen in Table 1. 
 
Table 1. Gradient table of the title 4, 5 (from each other separated) compounds 
 
Time (min.) A (%) B (%) 
0.0 90.0 10.0 
11.0 0.0 100.0 
11.5 90.0 10.0 
15.0 90.0 10.0 
 
Mass spectra were taken by Waters Q-TOF Premier mass spectrometer (Waters, Milford, MA, 
USA). Ionization mode was ES+, V-mode, capillary voltage: 2800 V, sampling cone: 30 V, 
extraction cone: 3.5 V, desolvation temperature: 500 °C, source temperature 120 °C. The scan time 
was by MS1 1.0 s, the inter scan delay 0.1 s, by MS2 0.3 s, and 0.05 s. Collision energy by MS1 was 
2.5 V, by MS2 15 – 30 V. 
 
MS/MS measurement 
Tandem mass spectrometric measurements were made with an Agilent 6460 QQQ instrument. Jet 
Stream ESI ion source was used in positive mode. Fragmentor voltage: 135 V, gas temperature: 300 
°C, gas flow rate: 13 l/min, nebulizer gas flow: 45 psi, sheathgas flow: 11 l/min, sheathgas 
temperature (heater) 400 °C, capillary voltage was 3500 V. The collision energy was 30 eV in both 
cases. 
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